中国社区医师
中國社區醫師
중국사구의사
Chinese Community Doctors
2015年
23期
42-43
,共2页
特发性肺纤维化%汉方己甲素%肺功能
特髮性肺纖維化%漢方己甲素%肺功能
특발성폐섬유화%한방기갑소%폐공능
Idiopathic pulmonary fibrosis%TET%Pulmonary function
目的：探讨泼尼松联合汉方己甲素(TET)治疗特发性肺纤维化(IPE)的临床效果。方法：收治IPF患者50例，分为对照组25例，单用泼尼松；联合组25例，在泼尼松基础上加用 TET 口服。结果：联合组治疗后6个月 VC%pred、DLco%pred、PO2明显改善，呼吸困难评分明显下降，血清 HA、LN、PC-Ⅲ、IV-C 含量明显下降(P＜0.05)。结论：与单用泼尼松治疗相比，泼尼松联合TET可进一步改善IPF的治疗效果。
目的：探討潑尼鬆聯閤漢方己甲素(TET)治療特髮性肺纖維化(IPE)的臨床效果。方法：收治IPF患者50例，分為對照組25例，單用潑尼鬆；聯閤組25例，在潑尼鬆基礎上加用 TET 口服。結果：聯閤組治療後6箇月 VC%pred、DLco%pred、PO2明顯改善，呼吸睏難評分明顯下降，血清 HA、LN、PC-Ⅲ、IV-C 含量明顯下降(P＜0.05)。結論：與單用潑尼鬆治療相比，潑尼鬆聯閤TET可進一步改善IPF的治療效果。
목적：탐토발니송연합한방기갑소(TET)치료특발성폐섬유화(IPE)적림상효과。방법：수치IPF환자50례，분위대조조25례，단용발니송；연합조25례，재발니송기출상가용 TET 구복。결과：연합조치료후6개월 VC%pred、DLco%pred、PO2명현개선，호흡곤난평분명현하강，혈청 HA、LN、PC-Ⅲ、IV-C 함량명현하강(P＜0.05)。결론：여단용발니송치료상비，발니송연합TET가진일보개선IPF적치료효과。
Objective:To investigate the clinical effect of prednisone combined with TET in the treatment of idiopathic pulmonary fibrosis.Methods:50 patients with IPF were selected.They were divided into the control group with 25 cases,and they were given prednisone alone.The united group with 25 cases,and they were given TET oral on the basis of prednisone.Results:The VC%pred, DLco% pred,PO2 of the united group were improved significantly after treatment for 6 months;the dyspnea scores decreased significantly,the serum HA,LN,PC- Ⅲ,IV-C content were decreased significantly(P<0.05).Conclusion:Compare with the prednisone alone treatment,prednisone combine with TET can further improve the therapeutic effect of IPF.
